Your Personal Checkup

Learn more

About Us

Our Mission

Improving the health of patients who suffer from neurological disorders. By applying an inclusive and personal brain monitor we make the treatment of neurological disorders more efficient, and more adequate for each individual patient.

Our Product

Montfort leverages smartphone's integral sensors capabilities, in order to provide a set of digital neurological tests which are:

  • Personal
  • Real-time
  • Inclusive
  • Remote
  • Inexpensive

Each module has a medical version to run at the clinic, and a consumer version to run in the patients natural environment.

Our Market

Our toolkit is suitable for monitoring almost any neurological disorder. Our Clinic version is suitable for neurologists, and other treatment providers, our Home version is used by the patient's themselves. Montfort's collective data is valuable for medical devices manufacturers and pharmaceutical companies, as we provide accurate medical indicators, in large numbers, and low costs.


The first time I faced the impact of neurological disorders was when my legendary high-school math teacher, Yair Cohen, was diagnosed with ALS. I have met him several times during his last years, witnessing the sad decline of a brilliant, humorous and adventurous person I admired. Yair's life has strengthen my inclination towards engineering, his death got me interested in neurophysiology. Contemplating between the two, I ended up studying both, believing that many patients can be helped by linking between these two disciplines. – YZ, CEO.

Over one billion people suffer from neurological disorders, with few professionals to diagnose and treat them. As a result, there is hardly any feedback between patients and their physicians. Patients’ treatment is based upon infrequent and short clinical visits, outside the patient’s natural environment, thus limiting the quality of care, reducing their quality of life, and increasing treatment costs. There is no real-time alert when anomaly occurs, which increases the risk involved with deploying a new treatment or modifying an existing one. On a larger scale, this lack of feedback is making the R&D of new drugs and medical devices more expensive and prolonged.

How It Works

We developed a “master app” which is installed on the patient’s smartphone and runs in the background of the device. The software links to all of the device integral sensors (touch-screen, GPS, microphone, etc.), captures the patient’s regular smartphone usage, analyzes the data and sends the results to our server for further analysis. In this manner we solve the compliance challenge – the patient does not have to actively complete any task. The data leaving the device is “digested,” which allows us to keep the patient’s privacy (no personal information leaves the device). Each monitor can be tailor-made for a specific patient; it is sampled in the patient’s natural environment and with a much higher frequency and accuracy than alternative methods. We provide indicators in three dimensions: Motor, Cognitive and Affective. Adopting this holistic approach reveals the treatment sweet-spot for each patient and provides alerts when anomaly is identified. It also serves as a diagnostic tool as many disorders resemble each other while being examined in the clinic. By grouping the information from various patients, we generate a collective feedback and alert, valuable for pharmaceutical companies, medical devices manufacturers, clinics and insurance companies.

What do we measure?

Each of our modules provides a set of medical indicators. The clinic version is used at the clinic, by the physician. The home version is used by the patient, providing the same indicators without the need to get to the clinic.


EncephaLog is a console allowing to execute and analyze static posturography and cognitive tests

Clinic Version:

Coming soon!

Home Version:

Coming soon!

Coming soon!

Our Team

Ziv Yekutieli

Co-Founder & CEO

Ziv is an electrical engineer and brain scientist, with over 10 years of experience linking between the two disciplines. For over 15 years, Ziv has been working in the Israeli high-tech industry and start-ups, where he gained big-data experience and management skills.

Dima Gershman

Co-Founder & Chief Data Officer

Information Systems Engineering expert, team leader & project manager.
Vast experience in end-to-end distributed systems architecture, large database design and high performance data analysis.

Marc Silverman

Chief iOS Officer

Marc was among the first to introduce a non-invasive and non-biased individual performance evaluation system, and developed a series of products dedicated to help individuals recover neuromotor function as a result of injury or disease. Marc is a named inventor on numerous issued patents in the medical device and have engineering and business experience.

G. Dar

Web Developer

Computer Scientist, linguist and designer. Over 10 years of experience in programming, design and education.

Moni Haimovich

Chief Android Officer

Aerospace engineer with over 15 years of experience in software development and architecture in large companies and startups in Israel and in the US. In the last 4 years specializing in the mobile and Android technology in Israeli and international companies

Advisory Board

Prof. Hagai Bergman

World-renowned neurologist, Hebrew University and Hadassa Medical Center.

Prof. Nir Giladi

Director of the Neurology Department at Tel Aviv Sourasky Medical Center (Ichilov)

Dr. Yoav Medan

Expert in brain-related technologies, Technion and InSightec.


  published on 1.5.2017
Israeli conference for neurosurgery
  published on 26.4.2017

Come and meet us in the Israeli conference for neurosurgery. The following talk will be given by Dr. A. Hadanny: DIAGNOSIS OF NORMAL PRESSURE HYDROCEPHALUS USING APPTUG-A SMARTPHONE APPLICATION OF INSTRUMENTED ‘TIMED UP AND GO’ May 12, 2017, 09:20, Galilion hotel, Israel.

Montfort-THM commercialization agreement
  published on 26.3.2017

In continuum to our collaboration, Montfort signs a commercialization agreement with Tel Hashomer Medical Research, Infrastructure and Services Ltd (THM) for the development of AppTUG-based NPH diagnosis tool. By using AppTUG, before and after lumbar puncture (LP), we are able to accurately measure the impact of the intracranial pressure reduction.

AppTUG launched in Assaf Harofeh hospital
  published on 2.2.2017

Montfort starts working in Assaf Harofeh hospital in collaboration with The Sagol Center for Hyperbaric Medicine and research. The hyperbaric chambers in the Sagol Center provide High Pressure Oxygen Treatment (HBOT), which helps treating patients who suffer from different acute or chronic medical conditions. AppTUG is used for motor assessments of patients who suffer from Cerebrovascular Accident (CVA a.k.a stroke) and Traumatic Brain Injury (TBI).

Israel Innovation Authority Grant
  published on 22.12.2016

December 2016 - Montfort obtains a grant from Israel Innovation Authority, the national project "Digital Israel".

AppTUG launch in Rambam health care campus
  published on 15.9.2016

Montfort's AppTUG is being used in Rambam outpatient clinic with PD patients, used for measuring treatment effect, and the performance of an experimental walker.

Monitoring in Shaare Zedek Medical Center
  published on 8.8.2016

Montfort AppTUG is being used in the Gaucher's disease center in Shaare Zedek Medical Center, Jerusalem, Israel. Gaucher's disease is caused by a recessive mutation in the GBA gene located on chromosome 1 and affects both males and females. About one in 100 people in the United States are carriers of the most common type of Gaucher disease. The carrier rate among Ashkenazi Jews is 8.9%.

Monitoring Parkinson's disease in Sheba Medical Center
  published on 31.7.2016

Montfort AppTUG is being used during treatment of Parkinson's disease (PD) patients, in Sheba medical center. Parkinson's disease is aneurological disorder that mainly affects the motor system. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. PD affects approximately seven million people globally and one million people in the United States. The proportion in a population at a given time is about 0.3% in industrialized countries. PD is more common in the elderly and rates rises from 1% in those over 60 years of age to 4% of the population over 80. The mean age of onset is around 60 years, although 5–10% of cases, classified as young onset PD, begin between the ages of 20 and 50. AppTUG is being used for motor assessment during the process of treatment calibration.

Monitoring essential tremor in Sheba Medical Center
  published on 2.5.2016

Montfort AppTUG is being used for motor evaluation of Essential Tremor (ET) patients, in Sheba medical center. Essential tremor (also referred to as benign tremor, familial tremor, or idiopathic tremor) is a neurological disorder that causes involuntary and rhythmic shaking.Trembling occurs most often in the patients hands. ET is one of the most common neurological diseases, with a prevalence of approximately 4% in persons age 40 and older and considerably higher among persons in their 60s, 70s, 80s.

Monitoring in Sheba Medical Center
  published on 8.3.2015

Monitoring Familial Dysautonomia ​patients in the movement disorder unit in Sheba Medical Center. For these patients a long-term and quantitative assessment is essential in order monitor their fluctuations in their condition

First launch of the montfort AppTUG test in Sourasky Medical Center
  published on 25.2.2015

Montfort AppTUG is being used in the neurology department in Tel-Aviv Sourasky Medical Center, for motor assessment in the outpatient clinic in order to measure lumbar puncture effect.

השקה ראשונה של בדיקת ה AppTUG של מונפורט במכון להפרעות תנועה בבית החולים שיבא
  פורסם בתאריך 1.12.2015

הבדיקה משמשת כחלק משלבי האבחון של חולי NPH - (NORMAL PRESSURE HYDROCEPHALUS). בטרם הנבדק עובר ניקור מותני (LP - lumbar puncture) הוא נבחן מספר פעמים ע"י ה AppTUG. כשעתיים לאחר הניקור המותני, הנבדק שוב עובר סדרה של בדיקות, ומתבצעת השוואה לביצועיו בטרם לניקור. האפליקציה מנהלת את רצף הבדיקות ומתעדת כל תנועה של החולה. בנוסף למדידת זמן ביצוע משימת ה TUG (שהוא כרגע האינדיקטור המדיד היחידי אשר נבדק ע"י הרופא), ניתן לקבל איפיון של כל אחד משלבי התנועה של הנבדק (קימה, צעידה, סיבוב, ישיבה) כולל בדיקת התנודתיות (SWAY) בציר קידמי-אחורי (Anterior-Posterior), וציר מרכזי-צידי (Medio-Lateral). השוואה דקדקנית זו מאפשרת להבחין טוב יותר בהשפעת הניקור, השוואה המהווה שלב מכריע באבחון המחלה ובקביעת המשך הטיפול המומלץ. הרופא מזין משוב סובייקטיבי שלו לתפקוד הנבדק במספר מימדים, וכל המידע נשמר ומשמש למעקב אחרי החולה. ברגע שהחולה או בני משפחתו מכירים את הבדיקה, ניתן לקיימה בקלות גם בבית החולה. לבדיקה אם הבדיקה רלוונטית לשימושכם אנא צרו עימנו קשר.

First launch of the montfort AppTUG test at the Movement Disorders Institute in Sheba Medical Center
  published on 1.12.2015

TUG (Timed Up and Go) is a diagnosis protocol useful for a variety of neurological disorders, among which is NPH - (NORMAL PRESSURE HYDROCEPHALUS). In the Movement Disorders Institute in Sheba Medical Center, before a patient undergoes a lumbar puncture (LP), he is tested by the AppTUG. The AppTUG app manages the test protocol and records every movement of the patient. Two hours after the LP, the patient undergoes another series of AppTUG tests. A comparison is then made between the AppTUG scores before and after the LP in order to the determine the impact of the pressure reduction. In addition to measuring the time taken to perform the TUG task (which is currently the only measurable indicator documented by the physician), a quantitative measurement is made of each phase of the subject's movement (getting up, walking, rotating, sitting) as well as sway calculation in front-rear axis (Anterior-Posterior), and a central-side axis (Medio-Lateral). This allows a detailed comparison which is crucial for proper diagnosis and choosing recommended treatment. The physician adds a subjective feedback to the patient’s performance in a short electronic form, and all the information is stored and used for future tracking of the patient. Once the patient or his family members are familiar with the test, it can be easily performed in the patient’s home. To check whether AppTUG is relevant for your use, please contact us.

September 2014

Montfort receives Tnufa grant from the Israeli OCS